Novartis boosts involvement in anti-Covid treatment
The biotech company and the pharmaceutical giant want to develop and market a drug with a unique approach for the prevention and treatment of Covid-19.
Keystone/Alexandra Wey
Swiss pharmaceutical company Novartis says it has signed a deal with biotech firm Molecular Partners to develop, manufacture and commercialise an anti-Covid-19 treatment drug.
The Basel-based company said the option and licence agreement was aimed at boosting a programme consisting of two antiviral therapeutic candidates, MP0420 and MP0423.
“It is clear that this pandemic calls for not just scientific solutions, but also for collaboration between companies to provide treatments in an area of high unmet need,” Novartis said in a statement publishedExternal link on Wednesday.
Molecular Partners will be responsible for the conduct of phase 1 and 2 trials.
Under the terms of the agreement, Molecular Partners will receive an initial payment of CHF60 million ($66.1 million). If Novartis takes up the option to both drugs, it will pay another CHF150 million to the biotech company.
In August, the Swiss government signed an agreement with Molecular Partners for priority access to a drug being developed to treat those severely ill with Covid-19.
It gives Switzerland access to the first 200,000 doses of the medicine, as well as up to three million further doses when requested.
Popular Stories
More
Foreign affairs
European nations snub Swiss-made weapons over Ukraine restrictions
Is reforming the Swiss pension system still possible, and if so, how?
Solutions still need to be found to meet the challenge of an ageing population and to improve the pensions of low-paid workers, the majority of whom are women.
What do you think Switzerland’s Alain Berset can bring to the Council of Europe?
The former interior minister is to become the first Swiss Secretary General of the Council of Europe – which issues should his five-year term focus on?
Swiss canton wants to test collection of electronic signatures for initiatives
This content was published on
St Gallen wants to become the first Swiss canton to use electronic signatures (e-collecting) for referendums or initiatives.
Swiss government launches attempt to secure 2038 Winter Olympics
This content was published on
After failing to host the Winter Olympics in 2030 and 2034, Switzerland is trying again - this time for the 2038 Winter Games.
Study highlights Swiss cantons’ failings over adoptions from India
This content was published on
A Swiss study released on Friday has revealed that cantons Thurgau and Zurich are responsible for shortcomings linked to adoptions of children from India.
Glacier melt causes changes to Swiss-Italian border
This content was published on
Switzerland has adapted its borders with Italy and France. The changes with Italy are linked to melting glaciers, while those with France concern a tram line and rivers in the Geneva region.
Zermatt restaurateurs sentenced for defying Covid-19 measures
This content was published on
A Swiss court has given three restaurateurs in Zermatt, who were arrested in 2021 after repeatedly ignoring police orders to close their establishment, suspended sentences and fines.
Report: one in five Swiss tunnels damaged, but safe
This content was published on
According to Switzerland's Federal Roads Office (Astra), national roads are in good condition overall. Almost one in five tunnels has moderate damage but they are safe, it said on Thursday.
Swiss couple sentenced for enslaving two housekeepers
This content was published on
A 46-year-old Swiss man has received a three year sentence, including nine months in jail, for exploiting, locking up and handcuffing two housekeepers he brought to Switzerland between 2018 and 2019.
Zurich Film Festival drops screening of ‘Russians at War’ documentary
This content was published on
The organisers of the Zurich Film Festival have decided not to show the controversial documentary Russians at War due to "safety considerations",
Swiss air traffic control upgrade slows tempo for safety reasons
This content was published on
The upgrade of Switzerland’s air traffic control system will take longer than anticipated following a series of malfunctions.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Roche bids to co-develop potential oral Covid-19 treatment
This content was published on
The Basel-based company has partnered with Atea Pharmaceuticals to develop, manufacture and distribute the latter’s oral anti-Covid-19 treatment.
Switzerland fast-tracks antiviral medication against Covid-19
This content was published on
Swissmedic, the agency that oversees the use of medicaments in Switzerland, took days to fast-track approval of the drug, which is produced under the brand name Veklury by US biopharmaceutical company Gilead Sciences. The application for its extended use was only received on Monday. It can now be used for a limited period of time to…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.